Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Diarmuid Coughlan

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersInformation systems development methodologies and practiceBiomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Feb 24, 2026
Schrodinger's Pricing: Conceptual and Practical Challenges of Conditional PAS in the NICE Technology Appraisal of Lorlatinib for Untreated ALK-Positive Advanced Non-small-cell Lung Cancer (Review of TA1103): An External Assessment Group Perspective.

Robert Hodgson, Diarmuid Coughlan

|Dec 09, 2024
New or repurposed: a novel classification system for the horizon scanning of innovative medicines.

Ross Fairbairn, Sola Akinbolade, Diarmuid Coughlan

|Oct 05, 2023
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective.

Diarmuid Coughlan, Oluwatomi Arisa, Katie Thomson

|Mar 23, 2023
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Giovany Orozco Leal, Nigel Armstrong, Ashleigh Kernohan

|Jan 13, 2022
Optimal Surveillance Strategies for Early-Stage Cutaneous Melanoma Post Primary Tumor Excision: An Economic Evaluation.

Vasileios Kontogiannis, Diarmuid Coughlan, Mehdi Javanbakht

|Nov 18, 2021
Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.

Luke Vale, Patience Kunonga, Diarmuid Coughlan

Pageof 2

Frequent Collaborators

2 joint publications

Luke Vale

2 joint publications

Patience Kunonga

2 joint publications

Catherine Richmond

2 joint publications

Dalvir Bajwa

2 joint publications

Ashleigh Kernohan

2 joint publications

Dawn Craig

1 joint publications

Hannah Lumley

1 joint publications

Robert Hodgson

1 joint publications

Margaret Astin

1 joint publications

Fiona Beyer

Frequent Collaborators

2 joint publications

Luke Vale

2 joint publications

Patience Kunonga

2 joint publications

Catherine Richmond

2 joint publications

Dalvir Bajwa

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on : Dec 11, 2016

9.6K
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

2.0K
See more related videos

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on : Dec 11, 2016

9.6K
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

2.0K
See more related videos